MacroGenics | MGNX - Trade Creditors


MacroGenics reported $4.29M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Genmab DKK 6M 2M Sep/2025
Geron USD 12.72M 1.46M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
MacroGenics USD 4.29M 500K Mar/2026
Merck USD 3.86B 541M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Xencor USD 7.92M 2.91M Mar/2026